Gloucester Pharmaceuticals
New York, US · 5 known investors
Bristol Myers Squibb is a biopharmaceutical company that develops and delivers medicines across oncology, hematology, neuroscience, immunology, and cardiovascular disease areas. The company focuses on creating transformative treatments for patients in high-need therapeutic categories.
Investors · 5
In the news
- Gloucester Pharmaceuticals - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation | PLOS Onejournals.plos.org · 2011
- Gloucester Pharmaceuticals, Inc. Completes $29 Million Financing - BioSpacebiospace.com · 2009
- Gloucester Pharma raises $20M in VC funding - Boston Business Journalbizjournals.com · 2009